Ngā kupu hautoa kōpae
Tohutoro APA (7th ed.)
Underwood, M., Urbaityte, R., Wang, R., Horton, J., Oyee, J., Wynne, B., . . . Sievers, J. (2024). Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies. MDPI AG.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoru Kātū Chicago (17th ed.)
Underwood, Mark, et al. Dolutegravir + Lamivudine Vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication Through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies. MDPI AG, 2024.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoro MLA (9th ed.)
Underwood, Mark, et al. Dolutegravir + Lamivudine Vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication Through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies. MDPI AG, 2024.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.